Testing effectiveness (Phase 2)Ended earlyNCT00881621What this trial is testingLapatinib and Capecitabine for Second Line Treatment of Pancreas CancerWho this might be right forPancreas Cancer Georgetown University 17
Not applicableUnknownNCT03840928What this trial is testingPatientSpot Formerly Known as ArthritisPowerWho this might be right forRheumatoid ArthritisAnkylosing SpondylitisFibromyalgia+61 more Global Healthy Living Foundation 40,000
Not applicableEnrolling By InvitationNCT06276764What this trial is testingThe LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas)Who this might be right forIPMN, PancreaticPancreas CancerPancreatic Cyst Adenocyte, LLC 500
Not applicableStudy completedNCT02068677What this trial is testingEvaluation of Injection Techniques in Celiac Plexus NeurolysisWho this might be right forPancreatic CancerPain AdventHealth 51
Not applicableStudy completedNCT04512209What this trial is testingCharacterization of Biophysical Stromal Properties in Human Cancer: Towards Personalized Computational OncologyWho this might be right forCarcinomatosis, PeritonealPancreas CancerOvarian Cancer+1 more University Hospital, Ghent 22
Not applicableStudy completedNCT02475499What this trial is testingIncretin-based Drugs and Pancreatic CancerWho this might be right forDiabetes Mellitus, Type 2 Canadian Network for Observational Drug Effect Studies, CNODES 886,172
Large-scale testing (Phase 3)Study completedNCT00789633What this trial is testingMasitinib in Combination With Gemcitabine for Treatment of Patients With Advanced/Metastatic Pancreatic CancerWho this might be right forPancreatic Cancer AB Science 353
Testing effectiveness (Phase 2)Looking for participantsNCT06244771What this trial is testingA Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid TumorsWho this might be right forAdvanced Solid Tumors With KRAS G12C MutationsSolid Tumor, AdultUnresectable Solid Tumor+5 more Frontier Medicines Corporation 403
Testing effectiveness (Phase 2)Ended earlyNCT02669914What this trial is testingMEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived TumorsWho this might be right forNon-Small Cell Lung CancerNonsmall Cell Lung CancerBreast Cancer+15 more Washington University School of Medicine 4
Testing effectiveness (Phase 2)Study completedNCT00923299What this trial is testingCetuximab and Trastuzumab in Treating Patients With Metastatic Pancreatic Cancer That Progressed After Previous Treatment With GemcitabineWho this might be right forPancreatic Cancer Institut du Cancer de Montpellier - Val d'Aurelle 33
Not applicableWithdrawnNCT01033500What this trial is testingCalcineurin Inhibitor-free, Steroid-free Immunosuppressive Regimen in Simultaneous Islet-Kidney Transplantation for Uremic Type 1 Diabetic PatientsWho this might be right forIslets of Langerhans TransplantationDiabetes Mellitus, Type 1Kidney Transplantation University of Wisconsin, Madison
Large-scale testing (Phase 3)Study completedNCT00662714What this trial is testingEarly Diagnosis of Diabetes Mellitus in Patients With Cystic FibrosisWho this might be right forCystic FibrosisDiabetes Mellitus Mukoviszidose Institut gGmbH 73
Testing effectiveness (Phase 2)UnknownNCT02461836What this trial is testingStudy of Stereotactic Body Radiation Therapy for Patients After Radical Resection of Pancreatic Cancer With Advanced Stages (T3 or N1)Who this might be right forPancreatic Cancer Second Affiliated Hospital, Zhejiang University, School of Medicine 513
Testing effectiveness (Phase 2)Study completedNCT00131911What this trial is testingSorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine TumorsWho this might be right forGastrinomaGlucagonomaInsulinoma+7 more National Cancer Institute (NCI) 93
Not applicableNot Yet RecruitingNCT07095621What this trial is testingFeasibility and Effectiveness of Three-day Discharge After Distal PancreatectomyWho this might be right forPancreatic NeoplasmsDistal Pancreatectomy (DP) IRCCS San Raffaele 35
Large-scale testing (Phase 3)Study completedNCT02395016What this trial is testingNimotuzumab Combinated With Gemcitabine in K-RAS Wild-type Locally Advanced and Metastatic Pancreatic CancerWho this might be right forPancreatic Cancer Biotech Pharmaceutical Co., Ltd. 90
Not applicableStudy completedNCT01809028What this trial is testingEvaluating the Number of Passes Required for Diagnostic Cell Block During EUS-FNA of Solid Pancreatic Mass LesionsWho this might be right forPancreatic Cancer AdventHealth 62
Testing effectiveness (Phase 2)Study completedNCT00260364What this trial is testingCombining Erlotinib Plus Bevacizumab and Gemcitabine Plus Capecitabine to Treat Advanced Pancreatic CancerWho this might be right forPancreatic Cancer Royal Marsden NHS Foundation Trust 44
Not applicableActive Not RecruitingNCT02531607What this trial is testingLipidomics, Proteomics, Micro RNAs and Volatile Organic Compounds (VOC)Who this might be right forPancreatic Neoplasms AdventHealth 500
Early research (Phase 1)Study completedNCT00544193What this trial is testingGemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal CancerWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerGastric Cancer+2 more City of Hope Medical Center 16